about
The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health.The effect of hydroxylated fatty acid-containing phospholipids in the remodeling of lipid membranes.Regulation of the cancer cell membrane lipid composition by NaCHOleate: effects on cell signaling and therapeutical relevance in glioma.The Novel Anticancer Drug Hydroxytriolein Inhibits Lung Cancer Cell Proliferation via a Protein Kinase Cα- and Extracellular Signal-Regulated Kinase 1/2-Dependent Mechanism.G protein-membrane interactions I: Gαi1 myristoyl and palmitoyl modifications in protein-lipid interactions and its implications in membrane microdomain localization.Accumulated bending energy elicits neutral sphingomyelinase activity in human red blood cells.Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia.Neuroprotective effect of 2-hydroxy arachidonic acid in a rat model of transient middle cerebral artery occlusion.The hydroxylated form of docosahexaenoic acid (DHA-H) modifies the brain lipid composition in a model of Alzheimer's disease, improving behavioral motor function and survival.Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease.G protein-membrane interactions II: Effect of G protein-linked lipids on membrane structure and G protein-membrane interactions.Triacylglycerol mimetics regulate membrane interactions of glycogen branching enzyme: implications for therapy.Changes in membrane organization upon spontaneous insertion of 2-hydroxylated unsaturated fatty acids in the lipid bilayer.Differential effect of 2-hydroxyoleic acid enantiomers on protein (sphingomyelin synthase) and lipid (membrane) targets.Multiple phospholipid substrates of phospholipase C/sphingomyelinase HR2 from Pseudomonas aeruginosaAlkanes are not innocuous vehicles for hydrophobic reagents in membrane studiesThe triacylglycerol, hydroxytriolein, inhibits triple negative mammary breast cancer cell proliferation through a mechanism dependent on dihydroceramide and Akt
P50
Q38175664-BE94293C-E161-46DC-A42B-6C9467FB0156Q38181846-3D5F626E-EDD3-4C89-9B06-79A34CF326B0Q38187774-DFD4AB71-0F88-4214-A734-292791671467Q38865029-D807A0F4-A1BB-4C84-8254-9387E84B722AQ40646725-478F8CD2-AE8A-415F-B69F-9A25D4FD2D7BQ42143355-C3B14D5A-CE0B-4888-9D61-2D1DE6AB6EFDQ42635149-B221A7DF-E734-492D-9F6D-C698843112B7Q46402375-938C9BE9-AB99-44B6-BB69-DB473460E41AQ46405445-0BDB1C41-609F-4AC2-A5BC-DFB47AE62816Q46953452-E3EBC7EC-C953-4052-B31E-C500D38714E0Q50916045-56467437-34DD-4A1A-B33D-DE09E658AA90Q50935561-E0B94102-8921-493C-9F58-5ABF1933A131Q52647457-9E0307A7-88A0-4ED9-8FBB-495157994874Q54385222-A312A8CD-0215-4781-AC3F-EB5C33E2C3D8Q63244815-E2789875-2CC9-4A4D-B5CA-1A5243D29E4AQ63244826-6461BF98-ACED-464C-AA60-61385B556520Q64086549-C635A36A-1517-4183-9760-A3D7DC9F4D49
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David J López
@ast
David J López
@en
David J López
@es
David J López
@nl
David J López
@sl
type
label
David J López
@ast
David J López
@en
David J López
@es
David J López
@nl
David J López
@sl
prefLabel
David J López
@ast
David J López
@en
David J López
@es
David J López
@nl
David J López
@sl
P106
P21
P31
P496
0000-0002-8353-2015